Bruk av frysetinte embryoer for høyeffektivitetsproduksjon av genmodifiserte mus
April 2nd, 2020
•Hirofumi Nishizono1,2,3*, Mohamed Darwish4,5*, Hideki Uosaki6,7, Nanami Masuyama8,9,10, Motoaki Seki8,11, Hiroyuki Abe3, Nozomu Yachie8,9,10,12,13, Ryohei Yasuda1
1Max Planck Florida Institute for Neuroscience, 2Life Science Research Center, University of Toyama, 3Department of Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, 4Graduate School of Innovative Life Science, University of Toyama, 5Department of Biochemistry, Faculty of Pharmacy, Cairo University, 6Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, 7Division of Stem Cell Research and Drug Development, Center for Development of Advanced Medical Technology, Jichi Medical University, 8Synthetic Biology Division, Research Center for Advanced Science and Technology, University of Tokyo, 9Institute for Advanced Biosciences, Keio University, 10Graduate School of Media and Governance, Keio University, 11Department of Molecular Oncology, Graduate School of Medicine, Chiba University, 12Department of Biological Sciences, School of Science, University of Tokyo, 13College of Arts and Sciences, University of Tokyo
Her presenterer vi en modifisert metode for kryopreservation av encellede embryoer, samt en protokoll som parer bruken av frysetinte embryoer og elektroporasjon for effektiv generering av genmodifiserte mus.
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved